IPCA begins commercial production at new Wardha API facility
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Midcap 150 and 2.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
IPCA Laboratories has started commercial production at its new greenfield manufacturing facility in Village Hingani, District Wardha. The plant will produce Drug Intermediates and Active Pharmaceutical Ingredients (APIs). The project involved a capital outlay of about Rs. 182 crores.
Adds new API production capacity, supporting future revenue growth. Rs. 182 cr capex now operational.